Efficacy and safety of ombitasvir/paritaprevir/ritonavir co-administered with ribavirin in adults with genotype 4 chronic hepatitis C infection and cirrhosis (AGATE-I)

Authors
Category Primary study
ConferenceHepatology
Year 2015
This article has no abstract
Epistemonikos ID: d7a20cc10a874d2d04e4fa0af272b8160efd4e8c
First added on: Nov 24, 2021